The reduction in brain BDNF after being treated with risperidone, along with BDNF gene polymorphisms, might be a part of the mechanism causing risperidone-induced type 2 diabetes in people with autism spectrum disorder. The gene discussed is BDNF; the disease is autism spectrum disorder.